The company has received final approval from the US Food and Drug
Administration (USFDA) to market its product which is a generic
version of Gleevec tablets, Zydus Cadila said in a statement.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-gets-usfda-nod-to-market-generic-cancer-drug/articleshow/75061780.cms
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment